Rituximab-reditux (100 mg, 500 mg)

DR. REDDYS LABORATORIES LTD. (INDIA)

“Rituximab” is the Drug / Molecule content in “Reditux”. Retuximab is produced through recombinant DNA technology. Retuximab is a monoclonal antibody against the protein found on the surface of immune system B cells. It induces cell death through antibody dependent cellular toxicity, complement dependent cytotoxicity, or apoptosis pathway.

Category:

Indication

Retuximab is used  for certain types of cancer such as Lymphomas, Leukemia, Transplant Rejection and some autoimmune disorders. Retuximab may be used alone or in combination with other drugs for the treatment of Non-Hodgkin’s Lymphoma and rheumatoid arthritis.

Note

Precaution

  1. Allergic reactions
  2. Severe infection.

Related products